The symposium will highlight the Institute's goal of fostering interdisciplinary research in cancer biology. An emphasis will be placed on integrative approaches to identify biomarkers and targets for novel therapeutic interventions, and research involving systematic genome-wide analyses of cancer biology.

Registration details will be available on this website in early 2008.

Keynote Address
"New Directions of Cancer Research"
David Baltimore, Ph.D.
Robert A. Millikan Professor of Biology, California Institute of Technology

Other Invited Speakers
"Discovery of Recurrent Gene Fusions in Prostate Cancer: A New Class of Biomarkers and Therapeutic Targets"
Arul M. Chinnaiyan, M.D., Ph.D.,
S.P. Hicks Endowed Professor of Pathology, Professor of Pathology and Urology, University of Michigan Medical School

"Signatures for Cancer Discovery"
Todd M. Golub, M.D.
Director, Cancer Program, Broad Institute and Carles A. Dana Investigator of Human Cancer Genetics, Dana-Faber Cancer Institute; Associate Professor of Pediatrics, Harvard Medical School; HHMI Investigator

"A Systems Biology Approach to Breast Cancer Subset Identification and Treatment"
Joe W. Gray, Ph.D.
Associate Laboratory Director for Life & Environmental Science, Life Sciences Division Director, Lawrence Berkeley National Laboratory

"Transcriptional networks in breast cancer biology"
Edison T. Liu, M.D.
Executive Director, Genome Institute of Singapore

"Pharmacogenetics of Leukemia Therapy"
Mary V. Relling, PharmD
Chair, Pharmaceutical Sciences Department, St. Jude Children's Research Hospital

"Towards Effective Cancer Therapeutics"
William R. Sellers, M.D.
VP & Global Head, Oncology, Novartis Institutes for Biomedical Research, Inc